[1] 何敏. 造影剂碘普罗胺的不良反应研究[J]. 临床医药文献电子杂志, 2019, 6(61): 151-152. He M. Study on the adverse reactions of the contrast agent iopromide[J]. Elect J Clin Med Liter, 2019, 6(61): 151-152. [2] 胡燕, 陆蓬, 戴洪修. CT增强患者心理干预护理[J]. 中国辐射卫生,2007,16(2):228-229. DOI: 10.3969/j.issn.1004-714X.2007.02.056 Hu Y, Lu P, Dai HX. Communication and psychological intervention for the patients during CT enhancement[J]. Chin J Radiol Health, 2007, 16(2): 228-229. DOI: 10.3969/j.issn.1004-714X.2007.02.056 [3] 王天宇, 于飞. 非离子型造影剂碘海醇在妇科盆腔CT检查中的应用效果及安全性分析[J]. 实用妇科内分泌电子杂志, 2020, 7(25): 129-130. DOI: 10.16484/j.cnki.issn2095-8803.2020.25.083. Wang TY, Yu F. The application effect and safety analysis of non-ionic contrast agent iohexol in gynecological pelvic CT examination[J]. Elect J Pract Gynecol Endocrinol, 2020, 7(25): 129-130. DOI: 10.16484/j.cnki.issn2095-8803.2020.25.083. [4] 谭世碧. 非离子型造影剂碘海醇在妇科盆腔CT检查中的应用效果及安全性观察[J]. 医药前沿, 2019, 9(5): 144-145. DOI: 10.3969/j.issn.2095-1752.2019.05.103. Tan SB. The application effect and safety observation of non-ionic contrast agent iohexol in gynecological pelvic CT examination[J]. Front Med, 2019, 9(5): 144-145. DOI: 10.3969/j.issn.2095-1752.2019.05.103. [5] 中华医学会放射学分会对比剂安全使用工作组. 碘对比剂使用指南(第2版)[J]. 中华医学杂志, 2014, 94(43): 3363-3369. DOI: 10.3760/cma.j.issn.0376-2491.2014.43.003. The Working Group on the Safe Use of Contrast Agents of the Radiology Branch of the Chinese Medical Association. Guidelines for the use of iodine contrast agents (Second Edition)[J]. Chin Med J, 2014, 94(43): 3363-3369. DOI: 10.3760/cma.j.issn.0376-2491.2014.43.003. [6] Kodzwa R. ACR manual on contrast media: 2018 updates[J]. Radiol Technol, 2019, 91(1): 97-100 [7] 甘淼, 刘畅, 赵丽, 等. CT对比剂急性不良反应的相关因素分析[J]. 中国医科大学学报,2020,49(5):458-462. DOI: 10.12007/j.issn.0258-4646.2020.05.016 Gan M, Liu C, Zhao L, et al. Analysis of related factors of acute adverse reaction caused by contrast agents used in computed tomography[J]. J China Med Univ, 2020, 49(5): 458-462. DOI: 10.12007/j.issn.0258-4646.2020.05.016 [8] 程小平, 朱雅健, 刘学良. 157例碘普罗胺注射液药品不良反应报告分析[J]. 中国药物警戒,2020,17(12):904-906,912. DOI: 10.19803/j.1672-8629.2020.12.12 Cheng XP, Zhu YJ, Liu XL. 157 cases of adverse drug reactions induced by iopromide injection[J]. Chin J Pharmacovigil, 2020, 17(12): 904-906,912. DOI: 10.19803/j.1672-8629.2020.12.12 [9] 陈丽英. 低剂量对比剂在肾脏肿瘤螺旋CT扫描中的应用[J]. 中国辐射卫生,2010,19(3):370-371. DOI: 10.13491/j.cnki.issn.1004-714X.2010.03.053 Chen LY. Effects of low dose contrast medium on renal tumor diagnosis with spiral CT scanning[J]. Chin J Radiol Health, 2010, 19(3): 370-371. DOI: 10.13491/j.cnki.issn.1004-714X.2010.03.053 [10] 李茜, 邢建峰, 王丰, 等. 非离子型与离子型对比剂不良反应及对肾功能指标影响观察[J]. 药物流行病学杂志,2018,27(8):518-521 Li Q, Xing JF, Wang F, et al. Study of adverse reactions of non-ionic and ionic contrast and their influence on renal function index[J]. Chin J Pharmacoepidemiol, 2018, 27(8): 518-521 [11] 刘书田, 黄杰. 等渗及次高渗对比剂引起患者发生对比剂肾病的比较[J]. 深圳中西医结合杂志, 2021, 31(8): 10-12. DOI: 10.16458/j.cnki.1007-0893.2021.08.005. Liu SH, Huang J. Comparison of isotonic and sub-hypertonic contrast agents causing contrast agent nephropathy in patients[J]. Shenzhen J Integr Tradit Chin Western Med, 2021, 31(8): 10-12. DOI: 10.16458/j.cnki.1007-0893.2021.08.005. [12] 覃慧. 非离子型对比剂注射速率对CT增强扫描患者不良反应的影响[J]. 中外医学研究, 2018, 16(11): 54-55. DOI: 10.14033/j.cnki.cfmr.2018.11.026. Qin H. The effect of non-ionic contrast agent injection rate on the adverse reactions of patients with enhanced CT scanning[J]. Chin For Med Res, 2018, 16(11): 54-55. DOI: 10.14033/j.cnki.cfmr.2018.11.026. [13] 唐雪苗. 两种造影剂在增强扫描CT中应用效果观察及不良反应的护理[J]. 现代临床护理,2010,9(9):26-28. DOI: 10.3969/j.issn.1671-8283.2010.09.011 Tang XM. Nursing observation of adverse reactions of two different kinds of contrast medium in CT scanning[J]. Mod Clin Nurs, 2010, 9(9): 26-28. DOI: 10.3969/j.issn.1671-8283.2010.09.011
